✦ LIBER ✦

Satavaptan improves ascites control in patients with cirrhosis

Book ID: 120843789
Publisher: Adis International Limited (now part of Wolters Kluwer Health)
Year: 2008
Weight: 120 KB
Volume: &NA;
Category: Article
ISSN: 1173-8324
DOI: 10.2165/00128413-200816510-00035

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Satavaptan treatment for ascites in pati

Satavaptan treatment for ascites in patients with cirrhosis: a meta-analysis of effect on hepatic encephalopathy development

✍ Hugh Watson, Peter Jepsen, Florence Wong, Pere Ginès… 📂 Article 📅 2013 🏛 Springer 🌐 English ⚖ 198 KB

Effects of a selective vasopressin V2 re

Effects of a selective vasopressin V2 receptor antagonist, satavaptan, on ascites recurrence after paracentesis in patients with cirrhosis

✍ Florence Wong; Pere Gines; Hugh Watson; Yves Horsmans; Paolo Angeli; Paul Gow; P 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 809 KB

Terlipressin improves renal function in

Terlipressin improves renal function in patients with cirrhosis and ascites without hepatorenal syndrome

✍ Aleksander Krag; Søren Møller; Jens H. Henriksen; Niels-Henrik Holstein-Rathlou; 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 200 KB 👁 1 views

Patients with advanced cirrhosis and ascites are characterized by circulatory dysfunction with splanchnic vasodilatation and renal vasoconstriction, which often lead to ascites. The vasoconstrictor terlipressin improves renal function in hepatorenal syndrome (HRS). The aim of this study was to evalu

Meta-analysis: the safety and efficacy o

Meta-analysis: the safety and efficacy of vaptans (tolvaptan, satavaptan and lixivaptan) in cirrhosis with ascites or hyponatraemia

✍ E. Dahl; L. L. Gluud; N. Kimer; A. Krag 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 288 KB

CONTROL OF ASCITES IN HEPATIC CIRRHOSIS

✍ Atkinson, M.; Paton, A.; Sherlock, Sheila 📂 Article 📅 1954 🏛 The Lancet 🌐 English ⚖ 580 KB

[90] LONG-TERM IMPROVEMENT OF SERUM SODI

[90] LONG-TERM IMPROVEMENT OF SERUM SODIUM BY THE V-RECEPTOR ANTAGONIST SATAVAPTAN IN PATIENTS WITH CIRRHOSIS AND HYPONATRAEMIA

✍ P. Gines; F. Wong; H. Watson 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 145 KB